Navigation Links
Embolization a Nonsurgical Way to Treat Fibroids
Date:3/18/2008

It works even after other therapies have failed, but many women unaware of this option, experts say,,

TUESDAY, March 18 (HealthDay News) -- Uterine artery embolization is an effective, non-surgical therapy for fibroids, even after a woman has had other treatments such as focused ultrasound surgery, a new study says.

But another team of researchers reports that many American women are unaware of embolization as a treatment option.

The two studies were to be presented Tuesday at the Society of Interventional Radiology's annual meeting, in Washington, D.C.

"If you're suffering with symptomatic fibroids, you don't have to have surgery. Uterine artery embolization is an excellent option," said the author of one of the studies, Dr. John Lipman, director of interventional radiology at Emory-Adventist Hospital in Atlanta. "There are some women who are silent sufferers. They basically hemorrhage each month because they know they don't want a hysterectomy and they feel it's the only option. So, they just sit on the sidelines because they don't want the surgery."

Uterine artery embolization (UAE), which is sometimes called uterine fibroid embolization, cuts off the blood supply to fibroids by blocking the uterine arteries. The procedure is minimally invasive, doesn't require general anesthesia, and often allows women to return to normal daily activities within a week, instead of the six weeks or so needed for recovery from a hysterectomy.

The downside to this procedure is that it's not effective for everyone, and in rare cases, the fibroids may recur, according to the Society of Interventional Radiology (SIR).

Other treatment options -- such as hysterectomy (surgical removal of the uterus) and myomectomy (surgical removal of individual fibroids) -- are available, as is magnetic resonance-guided focused ultrasound. This technique is also known as focused ultrasound surgery (FUS) or ablati
'/>"/>

Copyright©2008 ScoutNews,LLC.
All rights reserved  

0

GOOD

Page: 1 2 3

Related medicine news :

1. Terumo Launches the New AZUR(TM) Peripheral HydroCoil(R) Embolization System with Expanding Hydrogel Technology
2. Satisfaction After Fibroid Embolization Similar to Hysterectomy
3. Psychological intervention reduces postembolization pain
4. Few Women Hear About Uterine Fibroid Embolization Treatment Option Directly From Gynecologists
5. Study finds spine surgery yields greater benefits over nonsurgical treatments
6. Using coxibs and NSAIDs to treat osteoarthritis
7. New treatment effective in counteracting cocaine-induced symptoms
8. New treatment boosts muscle function in myasthenia gravis
9. HPV vaccine does not appear to be effective for treating pre-existing HPV infection
10. Free distribution of insecticide-treated mosquito nets can save lives
11. Kenyan malaria success strengthens call for free insecticide-treated nets for all
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Embolization a Nonsurgical Way to Treat Fibroids
Embolization a Nonsurgical Way to Treat Fibroids
(Date:5/22/2012)... quite common for a female song sparrow to stray ... next door, but a new study shows that sleeping ... is reported in The American Naturalist, found ... to have lower reproductive success than within-pair offspring. The ... ostensibly monogamous animals might be inclined to cheat. , ...
(Date:5/22/2012)... Health Sciences (NIEHS), part of the National Institutes of ... (SRP) at the University of California, San Diego. Over ... fund continued research on the molecular and genetic consequences ... hazardous waste sites. , It is the third funding ... funded by the NIEHS in 2000. , "The ...
(Date:5/22/2012)... Maureen Salamon HealthDay Reporter , , MONDAY, ... anticipated move sure to unleash heated debate, a ... men of all ages no longer be screened ... (PSA) blood test. The U.S. Preventive Services ... in prevention and evidence-based medicine, said PSA screening ...
(Date:5/22/2012)... 22 (HealthDay News) -- Hundreds of thousands of ... develop potentially life-threatening liver complications over the next ... Researchers evaluated medical insurance claims data and found ... advanced liver disease in 2008, and estimated that ... by 2015. The risk of developing advanced ...
(Date:5/22/2012)... thousands of psychiatrists attend their field,s largest annual meeting ... drug treatments report overwhelmingly on positive results. , ... the Journal of Clinical Psychopharmacology by two ... University, who analyzed the presentations given at two recent ... 278 studies presented at the 2009 and 2010 APA ...
Breaking Medicine News(10 mins):Health News:For monogamous sparrows, it doesn't pay to stray (but they do it anyway) 2Health News:UC San Diego Superfund Research Program receives $15 million grant renewal 2Health News:U.S. Advisers Say 'No' to Routine PSA Tests for Prostate Cancer 2Health News:U.S. Advisers Say 'No' to Routine PSA Tests for Prostate Cancer 3Health News:Hepatitis C Causing Liver Damage in Greater Numbers: Study 2Health News:Bias found in mental health drug research presented at major psychiatric meeting 2Health News:Bias found in mental health drug research presented at major psychiatric meeting 3
... ATLANTA, Jan. 7 The TV Teacher, LLC(TM) announces ... select,New York City schools: Queens, Bronx, and Staten Island. ... Alphabet Beats(TM) was co-created,by Susan Ellis, a mother struggling ... write the alphabet. After an unsuccessful two years ...
... B. Snow Jr., chairman and chief executive officer, Medco Health ... address the 27th Annual JPMorgan Healthcare Conference in San Francisco ... Francis Hotel, San Francisco, will begin at 8:30 a.m. PST ... are Richard J. Rubino, chief financial officer, and Robert S. ...
... 7 Boston Scientific Corporation (NYSE: BSX ... Morgan Health Care Conference in San Francisco.Jim Tobin, Chief ... January 14th, beginning at approximately 12:00 p.m. E.T. ... Chief Financial Officer will join Mr. Tobin in a ...
... Office (USPTO) has registered Guru Program® as a ... and honed by Tom Gable, of Gable PR, ... language said the mark covered: consulting services related ... and accounting services, health care, financial services, real ...
... 7 Agito Networks, Inc.(TM), the,company delivering ... today,announced that Technology Marketing Corporation,s (TMC(R)) Unified,Communications ... Networks,RoamAnywhere(TM) Mobility Router(TM) as a recipient of ... Agito Networks, award-winning RoamAnywhere ...
... and Telly Awards Honor CyberKnife Print and TV ... ARAY ), a global leader in ... has received three prestigious awards for its 2008 ... and RBG Marketing, who created the ads, received ...
Other Medicine News:Health News:New York Schools Receive Program for Children with Autism 2Health News:Medco CEO to Present at the 27th Annual JPMorgan Healthcare Conference 2Health News:Guru Program Pioneered by Tom Gable Receives Official Registration from USPTO 2Health News:Guru Program Pioneered by Tom Gable Receives Official Registration from USPTO 3Health News:Agito Networks' RoamAnywhere Mobility Router Wins Unified Communications Magazine's 2008 UC Excellence Award 2Health News:Agito Networks' RoamAnywhere Mobility Router Wins Unified Communications Magazine's 2008 UC Excellence Award 3Health News:Agito Networks' RoamAnywhere Mobility Router Wins Unified Communications Magazine's 2008 UC Excellence Award 4Health News:Accuray Receives Prestigious Awards for 2008 Advertising Campaign 2Health News:Accuray Receives Prestigious Awards for 2008 Advertising Campaign 3Health News:Accuray Receives Prestigious Awards for 2008 Advertising Campaign 4
(Date:5/22/2012)... Valeritas , the maker of V-Go™ Disposable Insulin ... the delivery of insulin designed especially for adults ... to support its state-of-the-art patient engagement program. ... people living with diabetes , and Valeritas ... management and support program designed to increase engagement ...
(Date:5/22/2012)... GeoVax Labs, Inc. (OTCQB/OTCBB: GOVX), an ... fight Human Immunodeficiency Virus (HIV) infections, today announced ... has opened enrollment for a Phase 1 trial ... vaccine is identical to the first ... except for the inclusion of granulocyte-macrophage colony-stimulating factor ...
(Date:5/22/2012)... 22, 2012  Eli Lilly and Company (NYSE: ... long-acting glucagon-like peptide 1 (GLP-1) analog being studied as ... primary endpoint of non-inferiority for mean 24-hour systolic blood ... 16 weeks. The results came from a Phase II ... using ambulatory blood pressure monitoring (ABPM) to characterize changes ...
Breaking Medicine Technology:Valeritas Inc. Selects dLife's New Diabetes Patient Engagement Solution For Valeritas' V-go Disposable Insulin Delivery Device 2Valeritas Inc. Selects dLife's New Diabetes Patient Engagement Solution For Valeritas' V-go Disposable Insulin Delivery Device 3Valeritas Inc. Selects dLife's New Diabetes Patient Engagement Solution For Valeritas' V-go Disposable Insulin Delivery Device 4HIV Vaccine Trials Network Opens Enrollment for Phase 1 Trial of GeoVax Labs' Second Generation HIV Vaccine 2HIV Vaccine Trials Network Opens Enrollment for Phase 1 Trial of GeoVax Labs' Second Generation HIV Vaccine 3HIV Vaccine Trials Network Opens Enrollment for Phase 1 Trial of GeoVax Labs' Second Generation HIV Vaccine 4Lilly Diabetes Presents Phase II Blood Pressure and Heart Rate Data on Investigational GLP-1 Analog Candidate, Dulaglutide, in Patients with Type 2 Diabetes at the 27th American Society of Hypertension Scientific Meeting 2Lilly Diabetes Presents Phase II Blood Pressure and Heart Rate Data on Investigational GLP-1 Analog Candidate, Dulaglutide, in Patients with Type 2 Diabetes at the 27th American Society of Hypertension Scientific Meeting 3Lilly Diabetes Presents Phase II Blood Pressure and Heart Rate Data on Investigational GLP-1 Analog Candidate, Dulaglutide, in Patients with Type 2 Diabetes at the 27th American Society of Hypertension Scientific Meeting 4Study provides documentation that tumor stem like cells exist in benign tumors 52543 1Study provides documentation that tumor stem like cells exist in benign tumors 52543 2Study provides documentation that tumor stem like cells exist in benign tumors 52543 3Risky driving puts P platers at high danger of crash 52541 1Risky driving puts P platers at high danger of crash 52541 2Salt marshes 3A A natural and unnatural history 9327 1
... Society Conference, MONMOUTH JUNCTION, N.J., June 13 ... Phase II clinical trial on its lead,investigational drug, ... developed for the treatment of cystic fibrosis (CF),patients ... Pseudomonas,aeruginosa. The Phase II data indicated that Arikace, ...
... Amsterdam Molecular,Therapeutics (Euronext: AMT), a leader in ... it has concluded enrollment and treated the last,patient ... AMT-011 (Glybera(R)) for,Hyperlipoproteinemia, a seriously debilitating and potentially ... countries,Germany and the United Kingdom of the European ...
Other Medicine Technology:Transave Announces Positive Phase II Results for Once-Daily Arikace(TM) in the Treatment of Cystic Fibrosis Patients Who Have Pseudomonas Lung Infections 2Transave Announces Positive Phase II Results for Once-Daily Arikace(TM) in the Treatment of Cystic Fibrosis Patients Who Have Pseudomonas Lung Infections 3Transave Announces Positive Phase II Results for Once-Daily Arikace(TM) in the Treatment of Cystic Fibrosis Patients Who Have Pseudomonas Lung Infections 4Transave Announces Positive Phase II Results for Once-Daily Arikace(TM) in the Treatment of Cystic Fibrosis Patients Who Have Pseudomonas Lung Infections 5AMT Prepares for Submission of Marketing Authorization Dossier for AMT-011 (Glybera(R)) 2AMT Prepares for Submission of Marketing Authorization Dossier for AMT-011 (Glybera(R)) 3
... Siremobil Iso-C3D C-Arm imaging system interface sets ... mobile C-arm imaging. Combining mobility and ... the cooperative technologies deliver the most complete ... imaging is the new standard in the ...
... OmniSight image guided surgery system offers ... in design and use. It provides ... to localize critical anatomy and plan ... gives surgeons an easy-to-use, technologically advanced ...
... the next evolution in transforaminal lumbar interbody ... instruments.. The T.L.I.F. SG Instruments feature a ... preparation instruments designed to support the technically ... range of instrument options to meet the ...
The ZEPHIR Anterior Cervical Plate System is the lowest profile plate clinically available....
Medicine Products: